Pronađeno: 1-5 / 5 radova

Autori: Tobias Joshua

>> Filter: Samo Article i Review

>> Sve godine

Naslov Phase II Trial of HER-Vaxx, a B-cell Peptide-Based Vaccine, in HER2-Overexpressing Advanced Gastric Cancer Patients Under Platinum-Based Chemotherapy (HERIZON) (Article)
Autori Tobias Joshua ... Andric Zoran G  ...  Nikolic Ivan V  Petrovic Zoran ...  (broj koautora 17) 
Info CLINICAL CANCER RESEARCH, (2024), vol. 30 br. 18, str. 4044-4054
Projekat Imugene Ltd.
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Final results of the phase II trial of HER-Vaxx, a B-cell peptide-based vaccine plus standard care of chemotherapy in patients with HER2-overexpressing advanced gastric cancer - (HERIZON) (Meeting Abstract)
Autori Tobias Joshua ... Andric Zoran G  Petrovic Z Nikolic Ivan V  ... (broj koautora 17) 
Info ANNALS OF ONCOLOGY, (2024), vol. 35 br. , Suppl. 2, str. S886-S886
Ispravka Web of Science   Članak   Elečas   Rang časopisa  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov HERIZON: A phase II study of HER-Vaxx (IMU-131), a HER2targeting peptide vaccine plus standard of care chemotherapy in patients with HER2+advanced stomach cancer - Dose-dependent anti-cancer antibodies correlating with improved clinical outcome (Meeting Abstract)
Autori Tobias Joshua Kundi Michael Garner-Spitzer E Zielinski Christoph Maglakelidze Marina Andric Zoran G  Petrovic Z Nagarkar R Chawla T Chong LO Nixon B Yavrom S Ede NJ Wiedermann Ursula 
Info ANNALS OF ONCOLOGY, (2023), vol. 34 br. , Suppl. 2, str. S864-S864
Ispravka Web of Science   Članak   Elečas   Rang časopisa  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov HERIZON: A phase 2 study of HER-Vaxx (IMU-131), a HER2t-argeting peptide vaccine plus SOC chemotherapy in patients with HER2+advanced stomach cancer - correlation of the antibody responses and clinical outcome (Meeting Abstract)
Autori Tobias Joshua Kundi Michael Garner-Spitzer E Zielinski Christoph Maglakelidze Marina Andric Zoran G  Petrovic Zeljko M Nagarkar R Chawla T Chong LMO Nixon B Yavrom S Ede NJ Wiedermann Ursula 
Info ANNALS OF ONCOLOGY, (2023), vol. 34 br. , Suppl. 1, str. S4-S4
Ispravka Web of Science   Članak   Elečas   Rang časopisa  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Cross-Reactive Effects of Vaccines: Heterologous Immunity between Tetanus and Chlamydia (Article)
Autori Stojanovic Marijana M  Lukic Ivana  Marinkovic Emilija Kovacevic Ana Miljkovic Radmila D Tobias Joshua Schabussova Irma Zlatovic Mario V  Barisani-Asenbauer Talin Wiedermann Ursula Inic-Kanada Aleksandra B 
Info VACCINES, (2020), vol. 8 br. 4, str. -
Projekat Institute for Specific Prophylaxis and Tropical Medicine, Medical University of Vienna, Austria; Austrian Research Promotion Agency (FFG) [822768]; Ministry of Education, Science and Technological Development of Republic of Serbia [451-03-68/2020-14/20017
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science   Scopus  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
>> Sve godine

Ispis zapisa u formatu:TXT | BibTeX